What is QUEST?
Benefits for participants:
• Medication at a cost from $135 per bottle or $130 per 10g sachet
• Connect with doctors experienced in prescribing medicinal cannabis (via the QUEST booking team)
• Participate in a non-invasive study from the comfort of your home
• Contribute to medical research and advancement of the understanding of medicinal cannabis and its impact on quality of life
What's involved for participants?
The Global QUEST Initiative will measure quality of life factors in a non-invasive way. Participants will complete online surveys as part of the study – and can do this from the comfort of their home. In addition, as part of standard care, a patient will need to consult their doctor periodically to discuss their results, receive additional scripts and to ensure continuity of care.
Understanding that some patients have mobility issues, the QUEST team have developed options for patient telehealth consults. Furthermore, medications for this trial will be couriered directly to patients.
Participants in the study can join for over 12-months. During this time, participants will be required to pay for their own medication. They will receive their medication at a subsidised cost from only $135 bottle of or $130 for 10 sachet (including delivery fee). Participation is voluntary and individuals can ‘opt-out’ at any time.
The Global QUEST Initiative team will be available throughout your journey for support.
Consistent access to affordable medication.
Privacy for participating patients is protected.
After the study ends, a summary of overall results will be available through your prescribing doctor.
Dr Richard Norman - Principal Investigator
Dr Christopher Reid - Co-Investigator
Dr Jun Chih - Project Statistician
Dr Karl Gruber - Research Officer
Professor Stephan Schug - Pain Management Advisor
Stephan Schug is Emeritus Professor and Honorary Senior Research Fellow in the Medical School of the University of Western Australia, Perth, Australia; he recently retired from his previous positions as Chair of Anaesthesiology and Pain Medicine and Director of Pain Medicine at Royal Perth Hospital, Australia.
His principal research interests include the management of acute and chronic pain, cancer pain, regional anaesthesia, the pharmacology of local anaesthetics and analgesics and quality improvement in health care.
Professor Schug studied medicine at the University of Cologne, Germany, where he also obtained his MD in clinical pharmacology and subsequently specialised in anaesthesia and pain medicine. He has written amongst others 80 research and 180 review papers. He is currently on editorial and review boards of several leading journals an active member of several pain and anaesthesia societies including just retired member of the Board of the Faculty of Pain Medicine of ANZCA (FPMANZCA).
Professor Serge Perrot - Pain Management Advisor
Professor Serge Perrot is a rheumatologist and pain specialist who divides his time between clinical work as Head of the Pain Centre at Cochin Hospital, Paris, France, and academic work as Professor of Clinical Pharmacology at Paris University. He is also a Councillor for the International Association for the Study of Pain, the past-President of the French Pain Society and works at the Paris INSERM Research Unit 987, part of the French National Institute of Health and Medical Research.
Following his fellowship at the Cochin and Bichat Hospitals between 1985 and 1989, Professor Perrot gained his certification in rheumatology and qualified as an MD from Paris Descartes University in 1989. Between 1991 and 1995 he was Assistant Professor at the Rheumatology Department of the Cochin Hospital. He continued his studies at the Paris 6 and Paris 12 Universities becoming a specialist in pain medicine (1997) and completing a PhD in Neuroscience (2001) and a Masters in Ethics and Philosophy (2016). His fields of interest and research include pain in osteoarticular disorders, the pharmacology of pain, patient education and innovative technology in pain management.
Professor Serge Perrot has been a clinical investigator for hundreds of studies on pain, rheumatology and osteoporosis and a national or international co-ordinator for 45 of these studies. He has published 140 articles in international medical journals. He is also a member of several international boards concerned with pain in rheumatology. In addition to his membership in several French rheumatological societies, Professor Perrot is a member of the International Association for the Study of Pain and the European Pain Society.
Dr Daniel Costa - Statistics Advisor
Dr Rachel Campbell - Sleep and Fatigue Advisor
Dr Leon Warne - Technical Advisor
Dr Leon Warne is a Pain Medicine Academic, R&D Consultant, Adjunct Senior Lecturer, Murdoch University, Honorary Senior Research Fellow, Curtin University, and Head of Research and Innovation, Little Green Pharma.
Dr Warne is a researcher and academic with over 15 years’ experience in the field of pain medicine. He holds a Bachelor of Science in Biomedical Science, a Doctorate of Veterinary Medicine, a Masters in pain medicine and a PhD in pain-management and assessment.
Leon leads a translational researcher group investigating a genetic treatment for people suffering chronic neuropathic pain. He maintains academic positions as an adjunct senior lecturer at Murdoch University and honorary senior research fellow at Curtin University. His passion for research and development focused on providing integrative medical solutions to improve patient quality of life led Leon to his current role as Head of Research and Innovation at Little Green Pharma. His clinical research interests are assessment and management of pain in patient’s incapable of self-reporting; and utilisation of novel drug delivery technologies to optimise the bioavailability and dosing efficacy of analgesic pharmaceuticals.